Athero Review
Current issue
Most read in this issue
- Statement CSAT on Consensus EAS 2021: Triglyceride-rich lipoproteins and their remnants – metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies
- Newer possibilities of slowing the development of chronic kidney disease and the role of dapagliflozin
- Bempedoic acid – a new drug to lower LDL-cholesterol level
- What have imaging studies with evolocumab yielded?
